Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM)

October 24, 2007 | Comments Off on Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM)

Cancer Letters. 2007 Dec 18;258(2):215-22. Epub 2007 Oct 18. [Link] Nasreen N, Mohammed KA, Lai Y, Antony VB. Division of Pulmonary & Critical Care Medicine, Department of Medicine, University of…

Immunohistochemical Detection of XIAP in Mesothelium and Mesothelial Lesions

October 24, 2007 | Comments Off on Immunohistochemical Detection of XIAP in Mesothelium and Mesothelial Lesions

American Journal of Clinical Pathology. 2007 Nov;128(5):783-7. [Link] Wu M, Sun Y, Li G, Desman G, Wang B, Gil J, Burstein DE. Department of Pathology, Mount Sinai School of Medicine,…

Increased pleural fluid adenosine deaminase levels in patients with malignant pleural effusions: a potential predictor of talc pleurodesis outcome

October 24, 2007 | Comments Off on Increased pleural fluid adenosine deaminase levels in patients with malignant pleural effusions: a potential predictor of talc pleurodesis outcome

Lung. 2007 Nov-Dec;185(6):349-54. Epub 2007 Oct 19. [Link] Yildirim H, Metintas M, Ak G, Erginel S, Alatas F, Kurt E, Metintas S, Ucgun I. Department of Chest Diseases, Medical Faculty,…

Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin

October 24, 2007 | Comments Off on Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin

Molecular Cancer. 2007 Oct 22;6(1):66 [Epub ahead of print]. [Link] Belyanskaya LL, Marti TM, Hopkins-Donaldson S, Kurtz S, Felley-Bosco E, Stahel RA. Abstract Background: The incidence of malignant pleural mesothelioma…

Morphologic and functional imaging of malignant pleural mesothelioma

October 24, 2007 | Comments Off on Morphologic and functional imaging of malignant pleural mesothelioma

European Journal of Radiology. 2007 Dec;64(3):356-66. Epub 2007 Oct 22. [Link] Yamamuro M, Gerbaudo VH, Gill RR, Jacobson FL, Sugarbaker DJ, Hatabu H. Department of Radiology and Surgery, Brigham and…

Outcomes After Extrapleural Pneumonectomy and Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma

October 24, 2007 | Comments Off on Outcomes After Extrapleural Pneumonectomy and Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma

Annals of Thoracic and Cardiovascular Surgery. 2007 Nov;84(5):1685-92; discussion 1692-3. [Link] Rice DC, Stevens CW, Correa AM, Vaporciyan AA, Tsao A, Forster KM, Walsh GL, Swisher SG, Hofstetter WL, Mehran…

Localized malignant pleural mesothelioma treated by a curative intent lobectomy: a case report

October 24, 2007 | Comments Off on Localized malignant pleural mesothelioma treated by a curative intent lobectomy: a case report

Annals of Thoracic and Cardiovascular Surgery. 2007 Oct;13(5):349-51. [Link] Turna A, Pekçolaklar A, Fener N, Gürses A. Department of Thoracic Surgery, Yedikule Teaching Hospital for Chest Diseases and Thoracic Surgery,…

Peritoneal mesothelioma: a review

October 24, 2007 | Comments Off on Peritoneal mesothelioma: a review

MedGenMed. 2007 May 10;9(2):32. [Link] Bridda A, Padoan I, Mencarelli R, Frego M. Clinica Chirurgica I, Department of Surgical and Gastroenterological Sciences, University of Padua, School of Medicine, Via Giustiniani…

Mesothelin targeted cancer immunotherapy

October 20, 2007 | Comments Off on Mesothelin targeted cancer immunotherapy

European Journal of Cancer. 2007 Oct 16; [Epub ahead of print] [Link] Hassan R, Ho M. Solid Tumor Immunotherapy Section, Laboratory of Molecular Biology, Center for Cancer Research, National Cancer…

Phase II Study of Vinflunine in Malignant Pleural Mesothelioma

October 20, 2007 | Comments Off on Phase II Study of Vinflunine in Malignant Pleural Mesothelioma

Journal of Clinical Oncology. Vol 25, No 30 (October 20), 2007: pp. 4751-4756 [Link] Talbot DC, Margery J, Dabouis G, Dark G, Taylor H, Boussemart H, Cadic V, Pinel MC,…

Categories